Keep Professional
Established in November 2020, Nano Diagnosis for Health Biotech (Guangzhou) Co., Ltd. (abbreviated as CNDH), has been jointly incubated by The GBA National Institute for Nanotechnology Innovation and National Engineering Research Center for Nanomedicine. CNDH is a high-tech enterprise focusing on the research, development, production and sales of in vitro diagnostic equipment and reagents for drugs of abuse, human diseases, and animal diseases.
100+
CE-certified products
100+
patent applications
70+
authorized patents
Guangdong Provicial People's Government
Ministry of Science and Technology
The GBA National Institute for
Nanotechnology Innovation
Chinese Academy of Sciences
Huazhong University of Science
and Technology
National Center for Nanoscience
and Technology
Guangzhou high-tech Industrial
Development Zone
Nano Diagnosis for Health Biotech
(Guangzhou) Co., Ltd
National Engineering Research
Center for Nanomedicine
丨
丨
丨
丨
丨
丨
丨
Establishment Background
Core Team Leader
From the perspective of the human life process, the nanoscale represents the critical threshold between non-living and living matter. Therefore, regulating life processes, disease onset and progression, as well as diagnosing, controlling, and treating diseases at the nanoscale is ultimately the most efficient approach.
Academician, Chinese Academy of Sciences (CAS)
Director, National Engineering Research Center for Nanoscience
President, The GBA National Institute for Nanotechnology Innovation (CanNano)
Academician, Chinese Academy of Sciences (CAS)
Director, National Center for Nanoscience
President, The GBA National Institute for Nanotechnology Innovation (CanNano)
Director of Technical Committee, National Engineering Research Center for Nanomedicine
Director of Technical Committee, National Engineering Research Center for Nanomedicine
Prof. Zhao Yuliang
The "Five Principles" for targeted delivery of antitumor nanomedicines state that an effective nanomedicine must be able to: “long circulation”, “tumor accumulation” “deep” , “cellular internalization” , and “drug release” .
Director, National Engineering Research Center for Nanomedicine
Chief Scientist, National Major Scientific Research Program (973)
Leader, National innovation team in key areas
Member of Expert Group, National Key R&D Program of Nanotechnology
Prof. Yang Xiangliang
Certifications
Contact Us
Have any question or feedback, feel free to reach out to us. We are always available to help.
Reach Out to Us
Please kindly provide us with your contact details such as your name, phone number, and email address so that we can get in touch with you at the earliest convenience.
+86 20 28399556
7F&8F, D Bldg. No. 136 Kaiyuan Avenue, Huangpu District, Guangzhou, China 510535